Failure of amygdalin to arrest B16 melanoma and BW5147 AKR leukemia

Cancer Res. 1976 Jun;36(6):2102-7.

Abstract

Parenteral amygdalin was found to be ineffective in C57BL/6 mice with B16 melanoma and in AKR mice with BW5147 lymphatic leukemia, in doses ranging from 50 to 5000 mg/kg.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Amygdalin / pharmacology
  • Amygdalin / therapeutic use*
  • Animals
  • Female
  • Leukemia, Experimental / drug therapy*
  • Leukemia, Experimental / etiology
  • Melanoma / drug therapy*
  • Melanoma / etiology
  • Melphalan / therapeutic use
  • Mice
  • Mice, Inbred AKR
  • Mice, Inbred C57BL
  • Neoplasms, Experimental / drug therapy
  • Neoplasms, Experimental / etiology
  • Nitriles / therapeutic use*

Substances

  • Nitriles
  • Amygdalin
  • Melphalan